Search - tctmd.com

Displaying 281 - 300 of 3096

Sort: Relevancy | Date

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

Presentation NY Valves 2025

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Jeremiah P. Depta

June 25, 2025

Presentation NY Valves 2025

BONAPART: A Novel Mechanical Leaflet Splitting Device

Presenter: Eberhard Grube

June 25, 2025

Presentation NY Valves 2025

Leave No Appendage Behind: Simultaneous Use of Two Watchman Devices to Occlude Bilobed Left Atrial Appendage

Presenter: Ashwin Mahesh

June 25, 2025

Presentation NY Valves 2025

Post-TTVR Function: Normal or Abnormal

Presenter: G. Burkhard Mackensen

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

Prosthetic Aortic Valve Function: Normal or Abnormal

Presenter: Kyle R. Lehenbauer

June 25, 2025

Presentation NY Valves 2025

Structural Valve Dysfunction: Overview of Definitions

Presenter: Philippe Pibarot

June 25, 2025

Presentation NY Valves 2025

AI-Based Simulation to Predict Device Performance and Procedural Success in SHD Interventions

Presenter: Omar K. Khalique

June 25, 2025

Presentation CTO 2025

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

Presenter: Ogechukwu Samuel Obi

March 01, 2025

Presentation CTO 2025

Sex-Based Differences on Clinical Outcomes in High-Risk Percutaneous Coronary Intervention with Left Ventricular Assist Devices

Presenter: Ogechukwu Samuel Obi

March 01, 2025

Presentation CTO 2025

The Next Generation of Mechanical Circulatory Support Devices

Presenter: Kevin Croce

March 01, 2025

Presentation CTO 2025

Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions Results From the European CTO Club Registry (ERCTO)

Presenter: Alfredo Galassi

March 01, 2025

Presentation CTO 2025

A Novel Non-Balloon-Based Coronary Intravascular Lithotripsy System: Device Overview, Early Experience and FORWARD CAD IDE Study Design

Presenter: Julian Strange

March 01, 2025

Presentation CTO 2025

High Risk Left Main Bifurcation PCI Supported by a Novel Low-profile Percutaneous Ventricular Assist Device

Presenter: Tai Pham

February 28, 2025

Presentation THT 2025

Clinical Trial Options

Presenter: Navin Kapur

February 13, 2025

Presentation THT 2025

What Are the Major Challenges?

Presenter: David Kandzari

February 13, 2025

Presentation THT 2025

How Helpful Can EFIC Be in the US?

Presenter: Graham Nichol

February 13, 2025

Presentation THT 2025

Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator

Presenter: Jennifer Cowger

February 13, 2025

Advertisement

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

BONAPART: A Novel Mechanical Leaflet Splitting Device

Leave No Appendage Behind: Simultaneous Use of Two Watchman Devices to Occlude Bilobed Left Atrial Appendage

Post-TTVR Function: Normal or Abnormal

Optimizing Mitral TEER in FMR: Technical and Device Strategies

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Prosthetic Aortic Valve Function: Normal or Abnormal

Structural Valve Dysfunction: Overview of Definitions

AI-Based Simulation to Predict Device Performance and Procedural Success in SHD Interventions

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

Sex-Based Differences on Clinical Outcomes in High-Risk Percutaneous Coronary Intervention with Left Ventricular Assist Devices

The Next Generation of Mechanical Circulatory Support Devices

Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions Results From the European CTO Club Registry (ERCTO)

A Novel Non-Balloon-Based Coronary Intravascular Lithotripsy System: Device Overview, Early Experience and FORWARD CAD IDE Study Design

High Risk Left Main Bifurcation PCI Supported by a Novel Low-profile Percutaneous Ventricular Assist Device

Clinical Trial Options

What Are the Major Challenges?

How Helpful Can EFIC Be in the US?

Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content